Cardiac Adaptation in Heart Failure, J. Holtz; Helmut Drexler; Hansj?rg Just
Автор: Giorgio Iervasi, Alessandro Pingitore Название: Thyroid and Heart Failure ISBN: 8847011426 ISBN-13(EAN): 9788847011427 Издательство: Springer Рейтинг: Цена: 10760.00 р. 15372.00-30% Наличие на складе: Есть (1 шт.) Описание: Both thyroid dysfunction and heart failure show a high prevalence in the adult population. Frequently, in clinical practice, a multidisciplinary approach is useful to optimize the management of patients with these conditions. This book presents the clinical, pathophysiological, and basic science aspects of thyroid - heart failure interactions.
Название: Management of heart failure ISBN: 047075379X ISBN-13(EAN): 9780470753798 Издательство: Wiley Рейтинг: Цена: 14882.00 р. Наличие на складе: Есть у поставщика Поставка под заказ.
Описание: * Offers an international perspective on current approaches to treating heart failure * An accessible reference for hospital-based specialists, providing an update on recent advances in therapeutics and pharmacology, as well as ongoing trials * Highlights the requirements of different categories of patients, e.g.
Автор: Masatsugu Hori; Yukio Maruyama; Robert S. Reneman Название: Cardiac Adaptation and Failure ISBN: 4431701338 ISBN-13(EAN): 9784431701330 Издательство: Springer Рейтинг: Цена: 12157.00 р. Наличие на складе: Есть у поставщика Поставка под заказ.
Автор: Masatsugu Hori; Yukio Maruyama; Robert S. Reneman Название: Cardiac Adaptation and Failure ISBN: 4431670165 ISBN-13(EAN): 9784431670162 Издательство: Springer Рейтинг: Цена: 6986.00 р. Наличие на складе: Есть у поставщика Поставка под заказ.
Автор: Ian M.C. Dixon; Jeffrey T. Wigle Название: Cardiac Fibrosis and Heart Failure: Cause or Effect? ISBN: 3319174363 ISBN-13(EAN): 9783319174365 Издательство: Springer Рейтинг: Цена: 22359.00 р. Наличие на складе: Есть у поставщика Поставка под заказ.
Описание: The unique biology of cardiac fibroblasts and related cells, such as cardiac myofibroblasts and valvular interstitial cells, distinguish them from other fibroblastic cells, a concept that is only beginning to be widely appreciated. Further, the natural signals that stimulate and inhibit cardiac fibrosis within these cells are not well understood. This volume compiles articles that address the molecular mechanisms that control the synthesis and secretion of the cardiac ECM. The book showcases chapters that highlight discussion of role of Transforming Growth Factor ? (TGF?), an important fibrogenic cytokine and its downstream effectors SMAD in many cardiac diseases. Further, the contributions highlight information to discuss endogenous inhibitors of cardiac fibrosis, as well as advances in tissue engineering specific to matrix in the heart. Finally, discussions of unifying mechanisms of matrix remodeling in valves and myocardium are presented. The mechanisms involved in the stimulation of cardiac fibrosis are not fully understood. In most cases the marginal attenuation of cardiac fibrosis as a result of a given therapy is a beneficial side-effect linked to other primary effects on other cells, especially cardiomyocytes. Very few drugs or agents are known to affect the function and dysfunction of cardiac fibroblasts and myofibroblasts alone. The book helps to translate the information gathered within to allow us to alter the course of fibrogenic events that are typical of cardiac fibrosis, and thereby reduce their burden on the patient and on society itself.
Автор: Ian M.C. Dixon; Jeffrey T. Wigle Название: Cardiac Fibrosis and Heart Failure: Cause or Effect? ISBN: 331937995X ISBN-13(EAN): 9783319379951 Издательство: Springer Рейтинг: Цена: 20896.00 р. Наличие на складе: Есть у поставщика Поставка под заказ.
Описание: The unique biology of cardiac fibroblasts and related cells, such as cardiac myofibroblasts and valvular interstitial cells, distinguish them from other fibroblastic cells, a concept that is only beginning to be widely appreciated.
Описание: In Harch of 1980, we organized the first symposium on how to evaluate new antiarrhythmic agents in which the participants included members of the Cardio-Renal Division of the Food and Drug Administration, academic investigators from the United States and Abroad and directors and imple- mentors of pharmacological research representing the pharmaceutical industry. By bringing together all three elements, it was hoped that better communication and under- standing would ensue to more rapidly bring new cardiac agents to the American public. This goal was important since a rather limited number of antiarrhythmic agents were and are currently available to treat patients with such disorders in the United States. These agents are needed not only for the treatment of patients with sustained ventricular tachyarrhythmias which produce life-threatening hemodynamic consequences but also and in fact more potentially important as a prophylactic measure in the high risk patient subject to sudden cardiac death. This book represents the proceedings of the third of these Symposiums whose purpose was to evaluate the clinical research methodology and models used in the evaluation of ne" antiarrhythmic agents for not only acute therapeutic inter- vention but also for the prophylaxis of sudden cardiac death. In addition, new devices have evolved over the past few years that can detect and treat life-threatening cardiac arrhythmias and the evaluation of efficacy and safety of these devices is detailed.
Описание: In Harch of 1980, we organized the first symposium on how to evaluate new antiarrhythmic agents in which the participants included members of the Cardio-Renal Division of the Food and Drug Administration, academic investigators from the United States and Abroad and directors and imple- mentors of pharmacological research representing the pharmaceutical industry. By bringing together all three elements, it was hoped that better communication and under- standing would ensue to more rapidly bring new cardiac agents to the American public. This goal was important since a rather limited number of antiarrhythmic agents were and are currently available to treat patients with such disorders in the United States. These agents are needed not only for the treatment of patients with sustained ventricular tachyarrhythmias which produce life-threatening hemodynamic consequences but also and in fact more potentially important as a prophylactic measure in the high risk patient subject to sudden cardiac death. This book represents the proceedings of the third of these Symposiums whose purpose was to evaluate the clinical research methodology and models used in the evaluation of ne" antiarrhythmic agents for not only acute therapeutic inter- vention but also for the prophylaxis of sudden cardiac death. In addition, new devices have evolved over the past few years that can detect and treat life-threatening cardiac arrhythmias and the evaluation of efficacy and safety of these devices is detailed.
Автор: Peacock Название: Short Stay Management of Acute Heart Failure ISBN: 1617796263 ISBN-13(EAN): 9781617796265 Издательство: Springer Рейтинг: Цена: 27950.00 р. Наличие на складе: Есть у поставщика Поставка под заказ.
Описание: This timely book is a road map for defining the care of acute heart failure patients in the short stay or observation unit setting. Produced in collaboration with the Society of Chest Pain Centers, this book provides an understanding of the diverse medical needs and solutions, administrative processes, and regulatory issues necessary for successful management. In an environment of increasing financial consciousness, medical practice is changing drastically. Short stay care is premier among the new specialties that cater to the complex balance of optimizing patient outcomes while minimizing fiscal burdens. The observation unit has proven to be an excellent arena for the care of acute heart failure, replete with opportunities to improve both medical management and quality metrics. Unique to the field, Short Stay Management of Acute Heart Failure, Second Edition is the only book of its kind, providing the medical, regulatory, and economic tools necessary to create and implement successful short stay management protocols and units for the care of the heart failure patient. It is an essential guide for health care professionals and for hospitals and institutions wishing to be recognized as quality heart failure centers as accredited by the Society of Chest Pain Centers.
Автор: Abraham Название: Cardiac Resynchronization Therapy in Heart Failure ISBN: 0781798442 ISBN-13(EAN): 9780781798440 Издательство: Lippincott Williams & Wilkins Рейтинг: Цена: 17846.00 р. Наличие на складе: Поставка под заказ.
Описание: A practical reference that gives physicians knowledge of the indications, techniques for implantation, complications, programming, and follow-up of CRT devices in patients with heart failure and intra- and interventricular conduction delays. It helps in preparing for the Heart Rhythm Exam/International Board of Heart Rhythm Examiners (IBHRE) exam.
Автор: R. Jacob; R. G?lch; G. Kissling Название: Cardiac Adaptation to Hemodynamic Overload, Training and Stress ISBN: 3642853285 ISBN-13(EAN): 9783642853289 Издательство: Springer Рейтинг: Цена: 15372.00 р. Наличие на складе: Есть у поставщика Поставка под заказ.
Автор: Domanski Michael Название: Oxford Textbook of Advanced Heart Failure and Cardiac Transp ISBN: 0198734875 ISBN-13(EAN): 9780198734871 Издательство: Oxford Academ Рейтинг: Цена: 21384.00 р. Наличие на складе: Есть у поставщика Поставка под заказ.
Описание: iOxford Textbook of Advanced Heart Failure and Cardiac Transplantationr is a focused and comprehensive work covering a new and rapidly growing cardiovascular subspecialty. Authored by eminent international experts it is the authoritative text on advanced heart failure and a central resource for clinicians caring for heart failure patients.
ООО "Логосфера " Тел:+7(495) 980-12-10 www.logobook.ru
